Related Experiment Videos
Is a "vanishing tumor" always a lymphoma?
J E C Bromberg1, M D Siemers, M J B Taphoorn
1Department of Neurology, University Medical Centre, Utrecht, the Netherlands. J.E.C.Bromberg@neuro.azu.nl
Neurology
|September 11, 2002
Summary
Regressing cerebral mass lesions can be challenging to diagnose. Primary CNS lymphoma (PCNL) is found in half of these cases, with complete resolution indicating a lower PCNL probability and better survival.
Area of Science:
- Neurology
- Radiology
- Oncology
Background:
- Regressing cerebral mass lesions present a diagnostic challenge in neuro-oncology.
- Differentiating between various etiologies, including primary CNS lymphoma (PCNL), is crucial for appropriate management.
Purpose of the Study:
- To analyze the clinical and radiologic characteristics of regressing cerebral mass lesions.
- To determine the frequency of primary CNS lymphoma (PCNL) in these cases.
- To investigate the correlation between lesion resolution and PCNL diagnosis and patient survival.
Main Methods:
- Retrospective review of 12 patients with regressing cerebral mass lesions.
- Clinical and radiologic data analysis.
- Correlation of imaging findings with histopathological diagnosis and patient outcomes.
Main Results:
- Primary CNS lymphoma (PCNL) was diagnosed in 50% of the patients.
- Patients with complete resolution of enhancing lesions were less likely to have PCNL.
- Complete lesion resolution was associated with longer survival.
Conclusions:
- Regressing cerebral mass lesions have variable etiologies, with PCNL being a significant consideration.
- Complete radiologic resolution of enhancing lesions may suggest a benign or treatment-responsive process, reducing the likelihood of PCNL.
- Early and accurate diagnosis is vital for improving patient outcomes in cases of cerebral mass lesions.